Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • Global United States
    < Back
    • Global
    • Annual Report
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Sciencearrow down
      < Back
    • Science
    • Areas of focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • People
    • Governance
    • Charitable Donations 
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Early Access Public Policy
  • Stories
Back

Post navigation

Previous
Next

Ipsen Logo

© Ipsen Pharma. All rights reserved – 2023

Usage policy

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.

Ipsen Logo

- 17 May 2023 - 1 mins read

© Ipsen Pharma. All rights reserved – 2023

Usage policy

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.

Post navigation

Previous
Next

Related Library

Ipsen sites – Wrexham, UK
17 May 2023 1 mins read

Ipsen sites – Wrexham, UK

Ipsen sites – Milton Park, UK
17 May 2023 1 mins read

Ipsen sites – Milton Park, UK

Ipsen sites – Signes, France
17 May 2023 1 mins read

Ipsen sites – Signes, France

Ipsen sites – Les Ulis, France
17 May 2023 1 mins read

Ipsen sites – Les Ulis, France

Ipsen sites – Dublin, Ireland
17 May 2023 1 mins read

Ipsen sites – Dublin, Ireland

Executive leadership team – Gwenan White
17 May 2023 1 mins read

Executive leadership team – Gwenan White

Executive leadership team – Sandra Silvestri
17 May 2023 1 mins read

Executive leadership team – Sandra Silvestri

Executive leadership team – Mari Scheiffele
17 May 2023 1 mins read

Executive leadership team – Mari Scheiffele

Executive leadership team – Aidan Murphy
17 May 2023 1 mins read

Executive leadership team – Aidan Murphy

Executive leadership team – Régis Mulot
17 May 2023 1 mins read

Executive leadership team – Régis Mulot

IPN price

€102.40

 €-0.60 (-0.58%)

  • Media
  • Investors
  • Partnering
  • Contact us
  • Leadership
  • Responsibility
  • Patients
  • Stories
  • Compliance
  • U.S. State Pricing Disclosures
  • Vigilance Alert: Identity Theft

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms of Use
  • Privacy
  • Consumer Health Data Privacy
  • Cookies
  • Your Privacy Choices

© Ipsen Biopharmaceuticals, Inc. All rights reserved - 2025

You are now leaving the Ipsen US website. To continue, please click on continue.

Continue